Anticoagulation Monitoring in the Intensive Care Unit
- PMID: 35212651
- DOI: 10.1097/CNQ.0000000000000394
Anticoagulation Monitoring in the Intensive Care Unit
Abstract
Patients with critical illness often display variable hypo- and hypercoagulable sequalae requiring intense monitoring and anticoagulation pharmacotherapy to prevent or treat inappropriate clot formation. It is imperative to understand the various stages of the clotting cascade and where each pharmacotherapy agent exerts its therapeutic effect. Common coagulation tests are utilized to monitor the areas of the clotting cascade and the effects that anticoagulant pharmacotherapy exhibits. Many novel coagulation tests are also in development. The purpose of this narrative review is to evaluate commonly utilized coagulation tests that monitor anticoagulation while in the intensive care unit.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Stevens SM, Woller SC, Kreuziger LB, et al. Antithrombotic therapy for VTE disease: second update of the CHEST Guideline and Expert Panel Report. Chest. 2021;160(6):2247–2259.
-
- Tripathi MM, Egawa S, Wirth AG, Tshikudi DM, Van Cott EM, Nadkarni SK. Clinical evaluation of whole blood prothrombin time (PT) and international normalized ratio (INR) using a Laser Speckle Rheology sensor. Sci Rep. 2017;7(1):9169.
-
- Dorgalaleh A, favaloro EJ, Bahraini M, Rad F. Standardization of prothrombin time/international normalized ratio (PT/INR). Int J Lab Hematol. 2021;43(1):21–28.
-
- Singh MY. Approach to the coagulopathic patient in the intensive care unit. Indian J Crit Care Med. 2019;23(suppl 3):S215–S220.
-
- Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med. 2005;165(10):1095–1106.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical